Real time uterine readiness for embryo transfer
Real time uterine readiness for embryo transfer
Non-invasive
Inmediate
Accurate
Non-invasive
Inmediate
Accurate
Seedchrony aims to increase pregnancy rates by 30% assessing uterine readiness for embryo transfer.
By preserving endometrial integrity (no biopsy needed) and providing prompt results, Seedchorny reads biomarker data in the uterus and provides real-time support to clinicians, to enhance the effectiveness of embryo transfer procedures. This enables doctors to be more informed about endometrial receptivity and conduct more effective and individualized embryo transfers.
Embryo Transfer Success is below 40%
Embryo Transfer Success is below 40%
Embryo Transfer Success is below 40%
Data from Spain 2021
105,000
Embryo transfers
36,000
Newborns
We will help to increase embryo transfer success
We will help to increase
embryo transfer success
We will help to increase embryo transfer success
We will help to increase
embryo transfer success
“A key factor for reproductive success in assisted reproduction treatments is the status of the maternal endometrium during embryo implantation and fetal development… Approaches that predict and prevent endometrial-factor infertility could substantially improve assisted reproduction treatment outcomes by supporting the establishment and maintenance of pregnancy”
Diaz-Gimeno P et al. Predicting risk of endometrial failure: a biomarker signature that identifies a novel disruption independent of endometrial timing in patients undergoing hormonal replacement cycles. Fertil Steril. 2024 Mar 20:S0015-0282(24)00190-0
“Embryo-endometrial synchrony is critical for successful implantation. There is an unmet need for improved precision in the evaluation of endometrial development to permit better synchronization of the embryo and the endometrium prior to implantation.”
Teh WT, McBain J, Rogers P. What is the contribution of embryo-endometrial asynchrony to implantation failure? J Assist Reprod Genet. 2016 Nov;33(11):1419-1430.
While selection of euploid embryos may be effective in overcoming a significant proportion of the age-related decline in reproductive efficiency, decrease in Implantation Rate, Clinical Pregnany Rate, and Live Birth Rates persists even when analyzing only euploid embryo transfers
Reig A et al. The impact of age beyond ploidy: outcome data from 8175 euploid single embryo transfers. J Assist Reprod Genet. 2020 Mar;37(3):595-602.
“In the aging endometrium, alterations occur at the molecular, cellular, and histological levels suggesting that aging has a negative effect on endometrial biology and may impair endometrial receptivity”
Pathare ADS et al. Endometrial receptivity in women of advanced age: an underrated factor in infertility. Hum Reprod Update. 2023 Nov 2;29(6):773-793.
“A key factor for reproductive success in assisted reproduction treatments is the status of the maternal endometrium during embryo implantation and fetal development”
“Embryo-endometrial synchrony is critical for successful implantation. There is an unmet need for improved precision in the evaluation of endometrial development to permit better synchronization of the embryo and the endometrium prior to implantation.”
“In the aging endometrium, alterations occur at the molecular, cellular, and histological levels suggesting that aging has a negative effect on endometrial biology and may impair endometrial receptivity”
Invest in Seedchrony
Invest in Seedchrony
Financed by
.jpg)
We have the trust of
Meet our team
%20en%20tama%C3%B1o%20grande.jpeg)
Mónica de la Vega
CEO / Co-Founder
Seedchrony inventor
+20 years in life science research, postdoc in
Cell Biology and Master in Biodesing
%20en%20tama%C3%B1o%20grande.jpeg)
Luis Artiles
COO / CTO / Co-Founder
AI/ML expert, Data driven innovator
+20 years in business consultancy as
manager and innovation director
Julio Herrero, MD
Clinical Trial Coordinator
IVF specialists. Head of the Assisted Reproduction
section of the Vall d'Hebron Hospital.
CEO of the Private Clinic CRA Barcelona
Editor of the Merck Atlas of Assisted Reproduction.
Melchor Carbonell, MD
Principal Investigator
IVF specialist. Gynecologist at CRA Barcelona
and at Val d'Hebron Hospital
Expert in implantation failures and pregnancy loss.
Anna Puigdollers, MBA
CFO
Senior CFO and Financial Consultant, with more than 15 years of experience as finance, operations and transformation director
Sussette Padilla
Regulatory Affairs and QMS Manager
Over 15 years of experience in Regulatory
Affairs and Quality Assurance for Medical
Devices
.jpg)
Gina Abelló
Clinical Affairs Manager
Expert in developmental biology
Over 10 years of experience in project
management within research and innovation
Adriano Feliu
Digital Product Designer and Marketing
Graduate in Film Direction
Specialist in Marketing, Branding, UI/UX
and Digital Design
Advisors
Toni Miró
CEO Linking Innovation
Medical devices expert
Julio Castro, PhD
CEO Palobiofarma
Serial entrepreneur
and Angel Investor
Roberto Costillas
CEO Fertypharm
Serial entrepreneur
and Angel Investor
Rosendo Garganta
CEO Devicare
Medical Device expert and
Angel Investor
.jpg)
